PULM
Closed
Pulmatrix Inc
6.61
-0.29 (-4.20%)
Last Update: 01 Jul 2025 23:26:00
Yesterday: 6.9
Day's Range: 6.53 - 6.92
Send
sign up or login to leave a comment!
When Written:
2.81
Pulmatrix Inc. is a clinical-stage biopharmaceutical company that develops innovative inhaled therapies for respiratory diseases. The company's proprietary inhaled drug delivery technology, called iSPERSE, enables the targeted delivery of drugs to the lungs, resulting in improved efficacy and reduced systemic side effects. Pulmatrix's pipeline includes several drug candidates for the treatment of respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis. The company's lead product candidate, Pulmazole, is an inhaled anti-fungal drug for the treatment of allergic bronchopulmonary aspergillosis (ABPA) in patients with asthma. Pulmatrix is headquartered in Lexington, Massachusetts, and was founded in 2003. The company went public in 2015 and is listed on the NASDAQ stock exchange under the ticker symbol PULM.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








